Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SMMT |
---|---|---|
09:32 ET | 221049 | 23.32 |
09:34 ET | 37317 | 23.025 |
09:36 ET | 118380 | 23.7497 |
09:38 ET | 221642 | 23.765 |
09:39 ET | 53698 | 23.79 |
09:41 ET | 71899 | 23.92 |
09:43 ET | 49891 | 23.76 |
09:45 ET | 30944 | 23.61 |
09:48 ET | 30078 | 23.5834 |
09:50 ET | 32120 | 23.55 |
09:52 ET | 25265 | 23.76 |
09:54 ET | 37613 | 23.75 |
09:56 ET | 24482 | 23.86 |
09:57 ET | 100431 | 24.06 |
09:59 ET | 131633 | 24.1 |
10:01 ET | 118859 | 24.0516 |
10:03 ET | 57456 | 24.0068 |
10:06 ET | 55353 | 23.78 |
10:08 ET | 59023 | 23.69 |
10:10 ET | 59822 | 23.88 |
10:12 ET | 52375 | 23.95 |
10:14 ET | 34465 | 23.9229 |
10:15 ET | 39128 | 24.0415 |
10:17 ET | 45463 | 24.065 |
10:19 ET | 51101 | 24.16 |
10:21 ET | 48139 | 24.205 |
10:24 ET | 55148 | 24.185 |
10:26 ET | 36789 | 24.125 |
10:28 ET | 25828 | 24.25 |
10:30 ET | 20906 | 24.16 |
10:32 ET | 54643 | 24.24 |
10:33 ET | 51513 | 24.3835 |
10:35 ET | 48856 | 24.26 |
10:37 ET | 31612 | 24.2 |
10:39 ET | 20154 | 24.235 |
10:42 ET | 27975 | 24.135 |
10:44 ET | 37962 | 24.0701 |
10:46 ET | 42370 | 24.145 |
10:48 ET | 14333 | 24.13 |
10:50 ET | 16494 | 24.01 |
10:51 ET | 27911 | 24.05 |
10:53 ET | 29463 | 24.11 |
10:55 ET | 67032 | 24.2 |
10:57 ET | 56257 | 24.23 |
11:00 ET | 72131 | 24.295 |
11:02 ET | 107369 | 24.4101 |
11:04 ET | 36758 | 24.305 |
11:06 ET | 7274 | 24.3015 |
11:08 ET | 29666 | 24.28 |
11:09 ET | 30848 | 24.37 |
11:11 ET | 20589 | 24.33 |
11:13 ET | 28924 | 24.2427 |
11:15 ET | 9468 | 24.35 |
11:18 ET | 35438 | 24.31 |
11:20 ET | 25367 | 24.365 |
11:22 ET | 31425 | 24.41 |
11:24 ET | 72816 | 24.32 |
11:26 ET | 18428 | 24.305 |
11:27 ET | 20846 | 24.37 |
11:29 ET | 8356 | 24.34 |
11:31 ET | 27515 | 24.15 |
11:33 ET | 61568 | 23.925 |
11:36 ET | 26381 | 24.18 |
11:38 ET | 20597 | 24.0656 |
11:40 ET | 27602 | 24.06 |
11:42 ET | 8934 | 24.02 |
11:44 ET | 28011 | 24.03 |
11:45 ET | 8894 | 24.12 |
11:47 ET | 50185 | 23.835 |
11:49 ET | 62052 | 23.84 |
11:51 ET | 19995 | 23.725 |
11:54 ET | 157775 | 23.285 |
11:56 ET | 23214 | 23.43 |
11:58 ET | 20788 | 23.48 |
12:00 ET | 22643 | 23.32 |
12:02 ET | 31348 | 23.34 |
12:03 ET | 17596 | 23.39 |
12:05 ET | 14183 | 23.4913 |
12:07 ET | 24034 | 23.52 |
12:09 ET | 60904 | 23.69 |
12:12 ET | 73478 | 23.7774 |
12:14 ET | 33695 | 23.85 |
12:16 ET | 20684 | 23.93 |
12:18 ET | 14469 | 23.835 |
12:20 ET | 13938 | 23.87 |
12:21 ET | 5897 | 23.87 |
12:23 ET | 52569 | 23.8737 |
12:25 ET | 14433 | 23.77 |
12:27 ET | 3389 | 23.8153 |
12:30 ET | 7653 | 23.775 |
12:32 ET | 10021 | 23.6845 |
12:34 ET | 21590 | 23.67 |
12:36 ET | 10251 | 23.8 |
12:38 ET | 10911 | 23.87 |
12:39 ET | 9738 | 23.94 |
12:41 ET | 10710 | 23.94 |
12:43 ET | 7389 | 24.0027 |
12:45 ET | 27824 | 24.01 |
12:48 ET | 37398 | 23.9799 |
12:50 ET | 11265 | 23.94 |
12:52 ET | 18163 | 24.0389 |
12:54 ET | 25433 | 24.04 |
12:56 ET | 9418 | 24.0101 |
12:57 ET | 13512 | 24.04 |
12:59 ET | 9661 | 23.9581 |
01:01 ET | 9490 | 23.94 |
01:03 ET | 8884 | 23.97 |
01:06 ET | 1730 | 23.98 |
01:08 ET | 14426 | 24.02 |
01:10 ET | 5041 | 24.0699 |
01:12 ET | 17378 | 24.035 |
01:14 ET | 10568 | 24.03 |
01:15 ET | 20835 | 23.965 |
01:17 ET | 12909 | 23.97 |
01:19 ET | 8533 | 24.03 |
01:21 ET | 18493 | 24.025 |
01:24 ET | 11043 | 23.94 |
01:26 ET | 15331 | 23.92 |
01:28 ET | 3956 | 23.93 |
01:30 ET | 6201 | 23.99 |
01:32 ET | 9668 | 24.05 |
01:33 ET | 35641 | 24.28 |
01:35 ET | 15641 | 24.2 |
01:37 ET | 15239 | 24.247 |
01:39 ET | 26055 | 24.265 |
01:42 ET | 11109 | 24.2801 |
01:44 ET | 26329 | 24.29 |
01:46 ET | 19893 | 24.325 |
01:48 ET | 74953 | 24.42 |
01:50 ET | 17142 | 24.3133 |
01:51 ET | 10800 | 24.34 |
01:53 ET | 19266 | 24.42 |
01:55 ET | 7514 | 24.38 |
01:57 ET | 3288 | 24.38 |
02:00 ET | 13281 | 24.43 |
02:02 ET | 19372 | 24.4299 |
02:04 ET | 25577 | 24.34 |
02:06 ET | 9084 | 24.3405 |
02:08 ET | 4990 | 24.3354 |
02:09 ET | 5320 | 24.396 |
02:11 ET | 14427 | 24.34 |
02:13 ET | 8021 | 24.37 |
02:15 ET | 6460 | 24.3815 |
02:18 ET | 16491 | 24.37 |
02:20 ET | 10685 | 24.47 |
02:22 ET | 87551 | 24.63 |
02:24 ET | 39072 | 24.53 |
02:26 ET | 37231 | 24.45 |
02:27 ET | 30390 | 24.47 |
02:29 ET | 16821 | 24.4281 |
02:31 ET | 11215 | 24.466611 |
02:33 ET | 39379 | 24.51 |
02:36 ET | 14999 | 24.47 |
02:38 ET | 16283 | 24.5 |
02:40 ET | 12889 | 24.4874 |
02:42 ET | 19110 | 24.5 |
02:44 ET | 16573 | 24.5108 |
02:45 ET | 7939 | 24.54 |
02:47 ET | 15763 | 24.525 |
02:49 ET | 23280 | 24.6153 |
02:51 ET | 11957 | 24.63 |
02:54 ET | 13565 | 24.6399 |
02:56 ET | 9281 | 24.65 |
02:58 ET | 16937 | 24.6508 |
03:00 ET | 30647 | 24.68 |
03:02 ET | 12072 | 24.65 |
03:03 ET | 14874 | 24.62 |
03:05 ET | 18958 | 24.56 |
03:07 ET | 12354 | 24.63 |
03:09 ET | 8776 | 24.62 |
03:12 ET | 9422 | 24.6894 |
03:14 ET | 15944 | 24.715 |
03:16 ET | 26121 | 24.73 |
03:18 ET | 18100 | 24.795 |
03:20 ET | 35281 | 24.835 |
03:21 ET | 20479 | 24.81 |
03:23 ET | 25480 | 24.84 |
03:25 ET | 24637 | 24.795 |
03:27 ET | 32722 | 24.815 |
03:30 ET | 12510 | 24.82 |
03:32 ET | 9270 | 24.78 |
03:34 ET | 12655 | 24.83 |
03:36 ET | 15081 | 24.918 |
03:38 ET | 17454 | 24.8771 |
03:39 ET | 24816 | 24.93 |
03:41 ET | 23565 | 24.87 |
03:43 ET | 22035 | 24.88 |
03:45 ET | 32925 | 24.84 |
03:48 ET | 24721 | 24.8525 |
03:50 ET | 24698 | 24.83 |
03:52 ET | 36470 | 24.78 |
03:54 ET | 103280 | 24.44 |
03:56 ET | 55222 | 24.425 |
03:57 ET | 107566 | 24.35 |
03:59 ET | 2415511 | 24.39 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Summit Therapeutics Inc | 16.8B | -106.1x | --- |
Vaxcyte Inc | 15.6B | -24.9x | --- |
Insmed Inc | 12.9B | -13.7x | --- |
Ascendis Pharma A/S | 9.3B | -15.7x | --- |
Revolution Medicines Inc | 7.7B | -12.5x | --- |
Viking Therapeutics Inc | 7.6B | -75.1x | --- |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.7B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 724.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.01 |
EPS | $-0.23 |
Book Value | $0.11 |
P/E Ratio | -106.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.